Your browser doesn't support javascript.
loading
The PanCareSurFup cohort of 83,333 five-year survivors of childhood cancer: a cohort from 12 European countries.
Grabow, Desiree; Kaiser, Melanie; Hjorth, Lars; Byrne, Julianne; Alessi, Daniela; Allodji, Rodrigue S; Bagnasco, Francesca; Bárdi, Edit; Bautz, Andrea; Bright, Chloe J; de Vathaire, Florent; Feijen, Elizabeth A M; Garwicz, Stanislaw; Hagberg, Oskar; Haupt, Riccardo; Hawkins, Mike M; Jakab, Zsuzsanna; Kremer, Leontien C M; Kuehni, Claudia E; Kuonen, Rahel; Lähteenmäki, Päivi Maria; Reulen, Raoul C; Ronckers, Cécile M; Sacerdote, Carlotta; Vu-Bezin, Giao; Wesenberg, Finn; Wiebe, Thomas; Winter, David L; Winther, Jeanette Falck; Zaletel, Lorna Zadravec; Kaatsch, Peter.
Afiliação
  • Grabow D; German Childhood Cancer Registry (GCCR), Institute for Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Center, Johannes Gutenberg University Mainz, Mainz, Germany. desiree.grabow@unimedizin-mainz.de.
  • Kaiser M; German Childhood Cancer Registry (GCCR), Institute for Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Center, Johannes Gutenberg University Mainz, Mainz, Germany.
  • Hjorth L; Department of Clinical Sciences, Skane University Hospital, Lund University, Pediatrics, Lund, Sweden.
  • Byrne J; Boyne Research Institute, 5 Bolton Square, East, Drogheda, Co. Louth, A92 RY6K, Ireland.
  • Alessi D; Childhood Cancer Registry of Piedmont, Cancer Epidemiology Unit, Citta' della Salute e della Scienza Hospital-University of Turin and Center for Cancer Prevention (CPO), Via Santena 7, 10126, Turin, Italy.
  • Allodji RS; Cancer and Radiation, Unit 1018 INSERM, University Paris-Saclay, Gustave Roussy, 39, rue Camille Desmoulins, 94805, Villejuif Cedex, France.
  • Bagnasco F; Epidemiology and Biostatistics Unit, Gaslini Children's Hospital, Via Gerolamo Gaslini, 5, 16148, Genova, Italy.
  • Bárdi E; 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary.
  • Bautz A; Kepler Universitätsklinikum, Linz, Austria.
  • Bright CJ; Danish Cancer Society Research Center, Strandboulevarden 49, 2100, Copenhagen, Denmark.
  • de Vathaire F; Centre for Childhood Cancer Survivor Studies, Institute of Applied Health Research, University of Birmingham, Birmingham, B15 2TT, UK.
  • Feijen EAM; Cancer and Radiation, Unit 1018 INSERM, University Paris-Saclay, Gustave Roussy, 39, rue Camille Desmoulins, 94805, Villejuif Cedex, France.
  • Garwicz S; Department of Pediatric Oncology, Emma Children's Hospital/Academic Medical Center Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
  • Hagberg O; Department of Clinical Sciences, Skane University Hospital, Lund University, Pediatrics, Lund, Sweden.
  • Haupt R; Regional Cancer Centre South, Lund, Sweden.
  • Hawkins MM; Epidemiology and Biostatistics Unit, Gaslini Children's Hospital, Via Gerolamo Gaslini, 5, 16148, Genova, Italy.
  • Jakab Z; Centre for Childhood Cancer Survivor Studies, Institute of Applied Health Research, University of Birmingham, Birmingham, B15 2TT, UK.
  • Kremer LCM; Hungarian Childhood Cancer Registry, 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary.
  • Kuehni CE; Department of Pediatric Oncology, Emma Children's Hospital/Academic Medical Center Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
  • Kuonen R; Princess Maxima Centre for Paediatric Oncology, Utrecht, The Netherlands.
  • Lähteenmäki PM; Swiss Childhood Cancer Registry, Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
  • Reulen RC; Department of Paediatrics, University Children's Hospital of Bern, University of Bern, Bern, Switzerland.
  • Ronckers CM; Swiss Childhood Cancer Registry, Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
  • Sacerdote C; Department of Pediatric and Adolescent Medicine, Turku University and Turku University Hospital, Turku, Finland.
  • Vu-Bezin G; Centre for Childhood Cancer Survivor Studies, Institute of Applied Health Research, University of Birmingham, Birmingham, B15 2TT, UK.
  • Wesenberg F; Department of Pediatric Oncology, Emma Children's Hospital/Academic Medical Center Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
  • Wiebe T; Childhood Cancer Registry of Piedmont, Cancer Epidemiology Unit, Citta' della Salute e della Scienza Hospital-University of Turin and Center for Cancer Prevention (CPO), Via Santena 7, 10126, Turin, Italy.
  • Winter DL; Cancer and Radiation, Unit 1018 INSERM, University Paris-Saclay, Gustave Roussy, 39, rue Camille Desmoulins, 94805, Villejuif Cedex, France.
  • Winther JF; Norwegian Cancer Register Department of Pediatric Medicine, Faculty of Medicine, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Zaletel LZ; Department of Clinical Sciences, Skane University Hospital, Lund University, Pediatrics, Lund, Sweden.
  • Kaatsch P; Centre for Childhood Cancer Survivor Studies, Institute of Applied Health Research, University of Birmingham, Birmingham, B15 2TT, UK.
Eur J Epidemiol ; 33(3): 335-349, 2018 Mar.
Article em En | MEDLINE | ID: mdl-29497894
ABSTRACT
Childhood cancer survivors face risks from a variety of late effects, including cardiac events, second cancers, and late mortality. The aim of the pan-European PanCare Childhood and Adolescent Cancer Survivor Care and Follow-Up Studies (PanCareSurFup) Consortium was to collect data on incidence and risk factors for these late effects among childhood cancer survivors in Europe. This paper describes the methodology of the data collection for the overall PanCareSurFup cohort and the outcome-related cohorts. In PanCareSurFup 13 data providers from 12 countries delivered data to the data centre in Mainz. Data providers used a single variable list that covered all three outcomes. After validity and plausibility checks data was provided to the outcome-specific working groups. In total, we collected data on 115,596 patients diagnosed with cancer from 1940 to 2011, of whom 83,333 had survived 5 years or more. Due to the eligibility criteria and other requirements different numbers of survivors were eligible for the analysis of each of the outcomes. Thus, 1014 patients with at least one cardiac event were identified from a cohort of 39,152 5-year survivors; for second cancers 3995 survivors developed at least one second cancer from a cohort of 71,494 individuals, and from the late mortality cohort of 79,441 who had survived at least 5 years, 9247 died subsequently. Through the close cooperation of many European countries and the establishment of one central data collection and harmonising centre, the project succeeded in generating the largest cohort of children with cancer to date.
Assuntos
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Sistema de Registros / Sobreviventes de Câncer / Neoplasias Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Child / Child, preschool / Female / Humans / Male País/Região como assunto: Europa Idioma: En Revista: Eur J Epidemiol Assunto da revista: EPIDEMIOLOGIA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Sistema de Registros / Sobreviventes de Câncer / Neoplasias Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Child / Child, preschool / Female / Humans / Male País/Região como assunto: Europa Idioma: En Revista: Eur J Epidemiol Assunto da revista: EPIDEMIOLOGIA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Alemanha